MREO
Mereo BioPharma Group PLC ADR
NASDAQ: MREO · HEALTHCARE · BIOTECHNOLOGY
$0.27
-2.89% today
Updated 2026-04-30
Market cap
$44.72M
P/E ratio
—
P/S ratio
89.45x
EPS (TTM)
$-0.25
Dividend yield
—
52W range
$0 – $3
Volume
1.6M
WallStSmart proprietary scores
25
out of 100
Grade: F
Strong Sell
Investment rating
3.3
Growth
D7.0
Quality
B+2.5
Profitability
F5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
-6.9
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$1.77
+560.21%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy4 Buy3 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Debt/equity 0.01x — low leverage
Risks
- Altman Z -6.90 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-7.68M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.51M | $10.00M | $0.00 | $500000.00 | $500000.00 |
| Net income | $-42.12M | $-29.47M | $-43.25M | $-41.88M | $-7.35M |
| EPS | — | — | — | — | $-0.25 |
| Free cash flow | $-48.83M | $-21.55M | $-33.53M | $-30.99M | $-7.68M |
| Profit margin | -2,795.09% | -294.66% | — | -8,375.60% | — |
Peer comparison
Smart narrative
Mereo BioPharma Group PLC ADR trades at $0.27. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -6.90, it sits in the distress. TTM revenue stands at $500000.00.
Frequently asked questions
What is Mereo BioPharma Group PLC ADR's stock price?
Mereo BioPharma Group PLC ADR (MREO) trades at $0.27.
Is Mereo BioPharma Group PLC ADR overvalued?
Smart Value Score 25/100 (Grade F, Strong Sell).
What is the price target of Mereo BioPharma Group PLC ADR (MREO)?
The analyst target price is $1.77, representing +560.2% upside from the current price of $0.27.
What is Mereo BioPharma Group PLC ADR's revenue?
TTM revenue is $500000.00.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-6.90 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio89.45x
ROE-82.20%
Beta0.38
50D MA$0.36
200D MA$1.26
Shares out0.16B
Float0.57B
Short ratio—
Avg volume1.6M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—